Medicus Pharma Ltd. Announces Voting Results Following the Annual and Special Meeting of Shareholders Jul 23, 2025 07:30AM
Quantum BioPharma (QNTM) Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari May 30, 2025 07:00AM
Quantum BioPharma (QNTM) Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario Apr 14, 2025 07:30AM
Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates Jan 17, 2025 07:30AM
Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against Nov 25, 2024 07:00AM


Aug 9, 2024 08:00PM FSD Pharma Announces Share Consolidation and Name Change
Aug 9, 2024 07:30AM FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research &
Jul 25, 2024 09:20AM 24/7 Market News Publishes Report Covering Functional Beverage Market, Featuring FSD Pharma
Jul 23, 2024 03:34PM FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders
Jul 23, 2024 10:29AM 24/7 Market News Publishes Report Covering Biotech Developments, Featuring FSD Pharma
Jul 4, 2024 08:00AM FSD Pharma Files Amended and Restated Material Change Report
Jun 28, 2024 05:02PM FSD Pharma (HUGE) Issues Corporate Update
Jun 28, 2024 05:00PM FSD Pharma provides Corporate Update
Jun 28, 2024 07:31AM FSD Pharma Inc. (HUGE) Wins Final Judgment to Confirm Arbitration Award of $3.06M Plus Interest Against Dr. Raza Bokhari
Jun 28, 2024 07:30AM FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd.
Jun 27, 2024 07:31AM FSD Pharma Inc. (HUGE) Receives Ethics Committee Approval for a Phase-1 Trial for Lucid-21-302
Jun 27, 2024 07:30AM FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia
Jun 13, 2024 07:32AM FSD Pharma (HUGE) Enters Into Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd and Other Business Applications
Jun 13, 2024 07:30AM FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications